Arkolith/Insider Trading/CMPI/Form 4

Wooldridge James

Chief Medical OfficerCheckmate Pharmaceuticals, Inc. (CMPI) · full profile →Form 4 · filed May 31, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
0 non-derivative · 5 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 31, 2022Disposed to issuer(D)96K——0
May 31, 2022Disposed to issuer(D)151K——0
May 31, 2022Disposed to issuer(D)27K——0
May 31, 2022Disposed to issuer(D)101K——0
May 31, 2022Disposed to issuer(D)55K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-020081) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML